It is best studied that the mitogen-activated protein kinase (MAPK) pathway stimulates the activity of AP-1, in TRAF2-deficient NPC cells, and the decrease of ERK1/2 phosphorylation was observed. This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.